Carolina Batista Ariza

Carolina Batista Ariza

Auto-generated profile, based on publicly available information

Carolina Batista Ariza

Department of Pathological Sciences, Biological Sciences Center, Londrina State University, Londrina, Paraná, Brazil

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Neurology Research International
Verified
Journal Article
Open access
PDF file
LGLayla T. Galindo
Layla T. Galindo
TFThais R. M. Filippo
Thais R. M. Filippo
PSPatricia Semedo
Patricia Semedo
CACarolina B. Ariza
Carolina B. Ariza
CMCaroline M. Moreira
Caroline M. Moreira
MPMarimelia Porcionatto
Marimelia Porcionatto
Therapy with mesenchymal stem cells (MSCs) has showed to be promising due to its immunomodulatory function. Traumatic brain injury (TBI) triggers immune response and release of inflammatory mediators, mainly cytokines, by glial cells creating a hostile microenvironment for endogenous neural stem cells (NSCs). We investigated the effects of factors secreted by MSCs on NSCin vitroand analyzed cytokines expressionin vitroin a TBI model. Ourin vitroresults show that MSC-secreted factors increase NSC proliferation and induce higher expression of GFAP, indicating a tendency toward differentiation into astrocytes.In vivoexperiments showed that MSC injection at an acute model of brain injury diminishes a broad profile of cytokines in the tissue, suggesting that MSC-secreted factors may modulate the inflammation at the injury site, which may be of interest to the development of a favorable microenvironment for endogenous NSC and consequently to repair the injured tissue.

20 October 2015 in Analytical Cellular Pathology
Verified
Journal Article
Open access
PDF file
MKMarina Okuyama Kishima
Marina Okuyama Kishima
KOKaren Brajão de Oliveira
Karen Brajão de Oliveira
CACarolina Batista Ariza
Carolina Batista Ariza
COCarlos Oliveira
Carlos Oliveira
RGRoberta Losi Guembarovski
Roberta Losi Guembarovski
MWMaria Angelica Ehara Watanabe
Maria Angelica Ehara Watanabe
CXCR4genetic polymorphisms, as well as their expression level, have been associated with cancer development and prognosis. The present study aimed to investigate the influence ofCXCR4rs2228014 polymorphism on its mRNA and protein expression in breast cancer samples. It was observed that patients presented higherCXCR4mRNA relative expression (5.7-fold) than normal mammary gland, but this expression was not correlated with patients clinicopathological features (nuclear grade, nodal status, ER status, PR status, p53 staining, Ki67 index, and HER-2 status). Moreover,CXCR4mRNA relative expression also did not differ regarding the presence or absence of T allele (p=0.301). In the immunohistochemical assay, no difference was observed for CXCR4 cytoplasmic protein staining in relation to different genotypes (p=0.757); however, high cytoplasmic CXCR4 staining was verified in invasive breast carcinoma (p<0.01). All in all, the results from present study indicated that rs2228014 genetic variant does not alterCXCR4mRNA or protein expression. However, this receptor was more expressed in tumor compared to normal tissue, in both RNA and protein levels, suggesting its promising applicability in the general context of mammary carcinogenesis.

8 February 2018 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Closed access
PDF file
FAFelipe Campos de Almeida
Felipe Campos de Almeida
BHBruna Karina Banin Hirata
Bruna Karina Banin Hirata
CACarolina Batista Ariza
Carolina Batista Ariza
RGRoberta Losi Guembarovski
Roberta Losi Guembarovski
KOKaren Brajão de Oliveira
Karen Brajão de Oliveira
MWMaria Angelica Ehara Watanabe
Maria Angelica Ehara Watanabe